OxiPath Health will sell a new pyridoxamine supplement for diabetics. Pyridoxamine is a derivative of vitamin B6 that inhibits oxidative stress-induced reactive molecules that are known to contribute to diabetic complications. OxiPath will also acquire a proven and patented method of pyridoxamine production that is significantly more cost effective than other methods enabling the Company to become the primary supplier to the supplement industry